AVANOS MEDICAL, INC. (AVNS) › Cost of RevenueAVANOS MEDICAL, INC. (AVNS) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $269.00M2017: $274.70M2018: $261.40M2019: $295.40M2020: $343.90M2021: $287.80M2022: $289.90M2023: $293.60M2024: $306.50M2025: $347.30M$347.30M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$347.30M+13.3%2024$306.50M+4.4%2023$293.60M+1.3%2022$289.90M+0.7%2021$287.80M-16.3%2020$343.90M+16.4%2019$295.40M+13.0%2018$261.40M-4.8%2017$274.70M+2.1%2016$269.00M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share